Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SPRR2G |
| Upstream (Parents) |
|---|
| (<<) CDH22 → SPRR2G |
| (<<) E2F4 → SPRR2G |
| (<<) GALR3 → SPRR2G |
| (<<) GSK3A → SPRR2G |
| (<<) KRT34 → SPRR2G |
| (<<) LOC100131581 → SPRR2G |
| (<<) PRSS36 → SPRR2G |
| (<<) SEMA5B → SPRR2G |
| (<<) SLC34A3 → SPRR2G |
| Downstream (Children) |
|---|
| SPRR2G → ACTC1 (>>) |
| SPRR2G → ATP10B (>>) |
| SPRR2G → CLCF1 (>>) |
| SPRR2G → CXADR (>>) |
| SPRR2G → CYP1A2 (>>) |
| SPRR2G → CYP4F2 (>>) |
| SPRR2G → DYRK1A (>>) |
| SPRR2G → EGFR (>>) |
| SPRR2G → FER1L4 (>>) |
| SPRR2G → FKSG2 (>>) |
| SPRR2G → FNDC4 (>>) |
| SPRR2G → HCN4 (>>) |
| SPRR2G → IL1F7 (>>) |
| SPRR2G → IL27 (>>) |
| SPRR2G → KLK12 (>>) |
| SPRR2G → MAP3K10 (>>) |
| SPRR2G → NMNAT1 (>>) |
| SPRR2G → PLA2G4D (>>) |
| SPRR2G → PLA2G6 (>>) |
| SPRR2G → RELL2 (>>) |
| SPRR2G → SLMO2 (>>) |
| SPRR2G → SYNGR4 (>>) |
| SPRR2G → TMPRSS11D (>>) |
| SPRR2G → TPSG1 (>>) |
| SPRR2G → ZNF224 (>>) |
